OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

PHASE4CompletedINTERVENTIONAL

Enrollment

290

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

March 31, 2007

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG

risedronate sodium

Trial Locations (7)

sanofi-aventis, US, Bridgewater

sanofi-aventis, Australia, Cove

sanofi-aventis, Belgium, Diegem

sanofi-aventis, Canada, Laval

sanofi-aventis, France, Paris

sanofi-aventis, Netherlands, Gouda

sanofi-aventi, UK, Guildford